Jpmorgan Chase & CO Enfusion, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Enfusion, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 126,693 shares of ENFN stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
126,693
Previous 303,332 58.23%
Holding current value
$1.36 Million
Previous $3.12 Million 54.8%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$9.85 - $11.5 $1.74 Million - $2.03 Million
-176,639 Reduced 58.23%
126,693 $1.41 Million
Q4 2024

Feb 12, 2025
BUY
$8.72 - $11.03 $831,103 - $1.05 Million
95,310 Added 45.82%
303,332 $3.12 Million
Q3 2024

Dec 26, 2024
BUY
$7.89 - $9.69 $1.41 Million - $1.73 Million
178,821 Added 612.38%
208,022 $1.97 Million
Q3 2024

Nov 08, 2024
BUY
$7.89 - $9.69 $1.41 Million - $1.73 Million
178,821 Added 612.38%
208,022 $1.97 Million
Q2 2024

Dec 26, 2024
SELL
$8.15 - $9.78 $1.46 Million - $1.75 Million
-178,821 Reduced 85.96%
29,201 $248,000
Q2 2024

Aug 12, 2024
BUY
$8.15 - $9.78 $88,240 - $105,888
10,827 Added 58.93%
29,201 $248,000
Q1 2024

Dec 26, 2024
SELL
$7.78 - $9.57 $1.48 Million - $1.81 Million
-189,648 Reduced 91.17%
18,374 $169,000
Q1 2024

May 10, 2024
SELL
$7.78 - $9.57 $51,301 - $63,104
-6,594 Reduced 26.41%
18,374 $169,000
Q4 2023

Dec 26, 2024
SELL
$7.87 - $10.23 $1.44 Million - $1.87 Million
-183,054 Reduced 88.0%
24,968 $242,000
Q4 2023

Feb 12, 2024
SELL
$7.87 - $10.23 $5,815 - $7,559
-739 Reduced 2.87%
24,968 $242,000
Q3 2023

Nov 14, 2023
SELL
$7.83 - $11.45 $155,950 - $228,049
-19,917 Reduced 43.65%
25,707 $230,000
Q2 2023

Aug 11, 2023
SELL
$7.54 - $11.22 $2.34 Million - $3.48 Million
-310,285 Reduced 87.18%
45,624 $511,000
Q1 2023

May 18, 2023
BUY
$10.07 - $12.1 $270,973 - $325,598
26,909 Added 8.18%
355,909 $3.74 Million
Q1 2023

May 11, 2023
BUY
$10.07 - $12.1 $3.09 Million - $3.72 Million
307,073 Added 1400.43%
329,000 $3.45 Million
Q4 2022

Feb 13, 2023
BUY
$8.72 - $14.17 $25,000 - $40,625
2,867 Added 15.04%
21,927 $212,000
Q3 2022

Nov 14, 2022
SELL
$9.66 - $15.13 $17,581 - $27,536
-1,820 Reduced 8.72%
19,060 $235,000
Q2 2022

Aug 11, 2022
BUY
$8.4 - $13.53 $44,604 - $71,844
5,310 Added 34.1%
20,880 $213,000
Q1 2022

May 11, 2022
SELL
$11.96 - $21.35 $1,207 - $2,156
-101 Reduced 0.64%
15,570 $198,000
Q4 2021

Feb 10, 2022
BUY
$17.8 - $22.94 $278,943 - $359,492
15,671 New
15,671 $328,000

Others Institutions Holding ENFN

# of Institutions
12
Shares Held
3.91M
Call Options Held
0
Put Options Held
0
View Full List

About Enfusion, Inc.

ENFN Quotes by TradingView
  • Ticker ENFN
  • Exchange NYSE
  • Sector Technology
  • Industry Software—Application
  • Shares Outstandng 67,001,700
  • Market Cap $721M
  • Description
  • Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or...
More about ENFN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email